Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Clinuvel Pharmaceuticals Ltd (CLVLY)

Clinuvel Pharmaceuticals Ltd (CLVLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion GlobeNewswire - Thu Aug 27, 12:42AM CDT

CLINUVEL PHARMACEUTICALS LTD announced its tenth consecutive annual profit and further rise in free cash in the financial year ended 30 June 2026...

CUVL : 6.77 (-11.44%)
CLVLY : 7.3500 (+3.09%)
CUV.AX : 9.180 (-12.74%)
CLINUVEL implements strategic reorganisation to refocus on U.S. markets GlobeNewswire - Wed Jul 22, 11:10PM CDT

MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic...

CUVL : 6.77 (-11.44%)
CLVLY : 7.3500 (+3.09%)
CUV.AX : 9.180 (-12.74%)
CLINUVEL’s ADS to commence trading on Nasdaq GlobeNewswire - Mon Jul 20, 12:37AM CDT

CUVL to trade on the highest tier – Global Select Market...

CLVLY : 7.3500 (+3.09%)
CUV.AX : 9.180 (-12.74%)
CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study GlobeNewswire - Fri Apr 24, 12:47AM CDT

“Totality of evidence” approach to evaluate SCENESSE®...

CLVLY : 7.3500 (+3.09%)
CUV.AX : 9.180 (-12.74%)
CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026 GlobeNewswire - Wed Apr 15, 1:18AM CDT

AAD 2026 reinforces CLINUVEL’s expertise in dermatology...

CLVLY : 7.3500 (+3.09%)
CUV.AX : 9.180 (-12.74%)
CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies GlobeNewswire - Sun Dec 7, 2025

EXECUTIVE SUMMARY VALLAURIX Research, Development & Innovation Centre to expand its existing facilities and capabilities core focus on accelerating...

CLVLY : 7.3500 (+3.09%)
CUV.AX : 9.180 (-12.74%)
CLINUVEL to advance novel pharmaceutical formulations in preclinical program GlobeNewswire - Sun Sep 28, 2025

Next generation sustained-release formulations for a variety of peptides...

CLVLY : 7.3500 (+3.09%)
CUV.AX : 9.180 (-12.74%)
CLINUVEL preparing upgrade of ADR program to Level II, Nasdaq uplist GlobeNewswire - Fri Aug 22, 2025

Executive summary plan to upgrade American Depository Receipt (ADR) program (CLVLY) to a Level II ADR listed on Nasdaq, expected before the end of...

CLVLY : 7.3500 (+3.09%)
CUV.AX : 9.180 (-12.74%)

Barchart Exclusives

Potential Bidders Are Looking at Shell’s Chemical Assets. How Investors Should View a Potential Sale. Barchart - 14 minutes ago
Potential bidders including ExxonMobil and LyondellBasell are looking at Shell’s U.S. chemicals assets in a deal that could fetch up to $8 billion. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.